1. Tullman MJ: Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care. 2013, 19: S15-20.
2. Loma I, Heyman R: Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol. 2011, 9: 409-16. 10.2174/157015911796557911.
3. Compston A, Coles A: Multiple sclerosis. Lancet. 2002, 359: 1221-1231. 10.1016/S0140-6736(02)08220-X.
4. Martinelli Boneschi F, Rovaris M, Capra R, Comi G: Mitoxantrone for multiple sclerosis. Cochrane Database Syst Rev. 2005, 4: CD002127-
5. Girouard N, Soucy N: Patient considerations in the management of multiple sclerosis: development and clinical utility of oral agents. Patient Prefer Adherence. 2011, 5: 101-108.